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Highlights: 
 Both the Shock Index and Systolic BP are good at predicting acute stroke mortality  
 SI and SBP are easily available in a clinical setting, and thus useful prognostic 
markers. 
 Shock index is particularly associated with 3-day morality in stroke. 
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Abstract 
Background : Shock index (SI) (ratio between heart rate and systolic blood pressure) has 
been shown to be associated with poor mortality outcomes in trauma and pneumonia; 
however it has yet to be examined in stroke. We aimed to examine the relationship between 
SI and acute outcomes of inpatient, 3-day and 7-day mortality in stroke. Secondly, we aimed 
to compare SI and systolic blood pressure (SBP) alone in predicting above outcomes. 
Methods: Data from a multicentre prospective cohort study conducted between October 
2009 and September 2012 in eight NHS trusts in East of England were analysed.  The 
relationships between SI, SBP and study outcomes were assessed using multivariable logistic 
regression models using mid-quintile groups as the reference category. Receiver operating 
characteristic (ROC) curves assessed the discriminating ability between the SI and SBP 
models. 
Results: A total of 2121 stroke patients were included (47.4%men; mean age 77.10 (sd) 
12.40) years. The lowest quintile of the SI, had an increased odds of 3-day and 7-day 
mortality, adjusted odds ratio (AOR) 2.45(95%CI:1.16-5.17) and 1.88(1.01-3.49), 
respectively. Patients with the highest quintile of SI also had increased odds of in-patient, 3-
day and 7-day mortality, AORs 1.85(1.17-2.92), 2.18(1.03-4.63) and 2.45(1.34-4.49), 
respectively. Similarly, SBP had a U-shape relationship with mortality. All measures had an 
ROC area under the curve >0.8 but there was no difference in the discriminating ability 
between SI and SBP.  
Conclusions: SI at extremely high and low values appeared to predict stroke mortality and 
appears to be particularly useful in predicting very early (3-day) mortality.   
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1.1 Introduction  
Stroke mortality is highest within first 30 days and both low and high blood pressure during 
acute stroke phase are associated with poor mortality outcomes.
 1-3
 Approximately 80% of 
patients have raised blood pressure immediately after a stroke and recent trials have shown 
that blood pressure lowering has benefits immediately after a stroke.  Thus, much effort has 
been made in examining the association between blood pressure and outcomes following a 
stroke, while there is a lack of research examining the effects of other physiological 
parameters of hemodynamics. For example, heart rate is a relatively understudied 
physiological factor that may be associated with stroke outcome; shown by the contrasting 
results from two observational studies.
 4,5
 
The Shock Index (SI) (the ratio between HR and SBP), was used initially to detect 
hypovolemia in patients with septic or hemorrhagic shock, indicated by a SI value of greater 
than 0.7.
 6,7
 In both these instances it has been a useful prognostic measure and has shown to 
be associated with poor clinical outcomes. . Whilst a lower SI may have prognostic 
significance in stroke serving as an indicator for severe neurological stress associated with a 
high systolic BP and reduced heart rate, large strokes with dysphagia or posterior circulation 
stroke presenting with vomiting are at high risk of aspiration pneumonia and may be 
associated with a higher SI as the result of sepsis and/or hypovolemia.  
The usefulness of shock index (SI) in predicting acute mortality outcomes in stroke has not 
been previously examined. In this paper, we examine the relationship between SI at the time 
of admission and acute outcomes of inpatient, 3 day and 7 day mortality, independently of 
other prognostic factors. We also examined the relationship between SBP and acute outcomes 
in stroke. We finally assessed the discriminating ability of both SI and SBP in predicting 
above outcomes. 
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2.1 Material and Methods 
2.2 Study Population and design 
The study population was drawn from the Anglia Stroke Clinical Network Evaluation Study 
(ASCNES). ASCNES’s aims, rationale, and study methods have already been previously 
described.
 8,9
 This was a multi-centre prospective cohort study using routinely collected 
stroke data from eight acute NHS trusts in East of England of all acute stroke admissions 
during between October 2009 and September 2011, with one year follow up. Only confirmed 
cases of ischemic and hemorrhagic strokes were eligible to be included in the study thus 
transient ischemic attacks (TIAs) and other neurological deficits were specifically excluded. 
Case ascertainment was verified by the patient’s medical history, clinical examination and 
evidence of ischemia or haemorrhage by neuroimaging (computed tomography (CT) or 
magnetic resonance imaging (MRI)). The study followed the ethical guidelines set out in the 
Declaration of Helsinki.
 10
  Ethical approval was obtained from the Norfolk Research Ethics 
Committee. The study was funded by the UK National Institute of Health Research, Research 
for Patient Benefit Programme (PB-PG1208-18240). 
We selected variables which have been previously shown to predict mortality outcome and 
other potential confounders for this outcome in stroke. The three mortality outcomes were 
death within 3 or 7 days of admission, or at any time during the admission. The prognostic 
variables used were age, sex, stroke type (ischemic or hemorrhagic), Oxfordshire Community 
Stroke Project (OCSP) classification based on clinical syndrome regardless of stroke subtype 
of ischemia or haemorrhage (total anterior stroke (TACS), lacunar stroke (LACS), posterior 
circulation stroke (POCS) and partial anterior circulation stroke (PACS)), pre-stroke 
modified Rankin scale (mRS),
 11,12
 thrombolysis therapy,  heart rate, systolic blood pressure 
on admission, dates of admission and discharge, and co-morbidities (hypertension, 
myocardial infarction, diabetes mellitus, hypercholesterolemia, chronic obstructive 
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pulmonary disease (COPD), peripheral vascular disease (PVD)) and use of antihypertensive 
medications on admission (yes/no).   
 
2.3 Outcomes  
Our primary endpoint was the inpatient mortality and the secondary endpoints were 3-day 
and 7-day mortality. The 3-day and 7-day mortality outcomes were derived using the date of 
admission and date of discharge data, thus any patient transferred to another hospital was 
excluded from the study.   
2.4 Exposures  
The primary predictor variable was the SI at presentation to a secondary care centre, 
calculated by dividing the heart rate by the systolic blood pressure (SBP). Both SBP and heart 
rate were measured on the admission by clinical teams from 8 NHS stroke services using the 
validated BP machines. For the primary analysis the continuous SI was divided into quintiles 
to better understand the relationship between different level of SI and chosen outcomes. In a 
secondary analysis we categorized the SI into three categories defined by clinical cut off 
points, as follows. For clinical cut points we used the normal SI range (0.5-0.7) as the 
reference category with a SI <0.5 as having a low SI score and those with >0.7 classed as 
those with hemodynamic sign of shock.  The secondary predictor variable was SBP. 
2.5 Statistical analysis 
Data were analysed using SPSS version 21.0 (Chicago, Illinois, USA). Descriptive statistics 
such as the Kruskal-Wallis and Chi square tests for trend were used to assess the difference 
between patient characteristics among the quintiles of the SI and SBP independently.  
Multiple logistic regression models were constructed for each outcome with the arithmetic 
quintile groups of SI as the primary exposure variable. For each outcome, model A adjusted 
for age and sex, model B adjusted for age, sex and pre-stroke mRS, model C adjusted for age, 
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sex, pre-stroke mRS , OCSP classification and stroke type and model D additionally adjusted 
for previous co-morbidities, antihypertensive use, and whether the patient was treated for 
thrombolysis or not. When examining the relationship with SBP only fully adjusted model 
(Model D) was used for each mortality outcomes. The stratified analysis used the 
traditionally defined normal values of SI as the exposure for each outcome. We used model D 
to examine the usefulness of SI stratified by age groups (<65, ≥65), sex (male and female), 
OCSP classification (Other than TACS and TACS), prestroke mRS categories (no to 
moderate disability (mRS <3) and severe prestroke disability (mRS ≥3)) and for ischemic 
stroke type (due to low numbers for hemorrhagic stroke). The variable of interest was 
excluded from the each of the respective stratified analyses (e.g. age was not included in the 
model in age stratified analysis). In all analyses, missing data were excluded from the 
individual analyses.  
Receiver operating characteristic (ROC) curves were used to evaluate the discriminating 
ability for both SI and SBP for each morality outcomes. The ROC curves used the predicted 
values from each logistic regression model and a combined analysis tested for equality 
between each of the curves. We used Stata V.13 (STATA Corp, Texas, USA) for this 
analysis.  
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3.1 Results 
The sample consisted of 2,625 patients admitted to stroke services of the participating 
hospitals during the study months; 266 patients were transferred out or did not meet the study 
inclusion criteria detailed in the methods and therefore were excluded. A further 238 patients 
were excluded due to missing heart rate or systolic blood pressure data, thus a total of 2,121 
patients were eligible. Of them 47.4% were male, the mean age was 77.10 (sd, 12.40) years, 
87.5% had an ischemic stroke and 42.8% had a pre-stroke mRS of 0. PACS was the most 
common OCSP classification (35.2%) and over half (59.2%) of the patients had previous 
history of hypertension.  In this study, inpatient mortality was 19.8% and acute mortality 
figures were 7.4% and 11.6% for 3-day and 7-day mortality, respectively. 
 
Table 1 shows the distribution of sample characteristics across the quintiles of the shock 
index. There was a higher proportion of ischemic strokes in the fifth quintile in comparison to 
the first quintile (91.3% vs. 85.6, p <0.03). The inpatient mortality was the highest in the fifth 
quintile at 30.1% while the other quintiles have a lower proportion of inpatient morality at 
around 17%. For both the 3-day and 7-day mortality there appears to be a U/J-shaped 
relationship according to SI quintiles. In these outcomes the mortality rate appears to be 
higher at the fifth and first quintiles while the lowest at the third quintile.  
 
Supplementary Table 1 highlights the sample characteristics across the quintiles of SBP. 
There was a higher proportion of ischemic strokes in the first quintile in comparison to the 
fifth quintile (90.9% vs. 80.2%). Similar to SI, SBP exhibits a U/J shape relationship with the 
mortality outcomes.  
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Table 2 shows the logistic regression analysis that presents the likelihood of inpatient 
mortality, 3-day mortality or 7-day mortality. After adjusting for all the covariates, stroke 
patients who were in the highest SI quintile on admission were at an increased likelihood of 
inpatient mortality, 3-day mortality and 7-day morality in comparison to stroke patients in the 
third quintile of the SI (reference category) with the strongest association for inpatient 
mortality. Patients in the first quintile did not appear to have an increased likelihood of 
inpatient morality, however these patients had an increased likelihood of 3-day morality with 
an odds ratio (OR) of 2.45 (95% CI 1.16-5.17) compared to the third quintile. Similarly 
stroke patients with low SI had an increased likelihood of a 7-day mortality with an OR of 
1.88 (95% 1.01-3.49) compared to the third quintile.  
 
Table 2 also describes the association between SBP and the mortality outcomes using the 
fully adjusted model (Model D). Higher and lower quintiles of SBP pressure are associated 
with an increased likelihood of in-patient and 7 day mortality. Unlike SI only high quintiles 
of SBP are associated with 3 day mortality (OR 2.58 (95% CI:1.15-5.79)).   
 
Supplementary Table 2 shows the relationship between SI categories defined using lower and 
upper limit of clinical normal range of SI as the cut off points and the likelihood of in-patient 
mortality, 3-day mortality and 7-day mortality stratified by age groups (<65 and ≥65 years), 
sex (males and females), binary OCSP classification (TACS and others) and pre-stroke mRS 
categories (no to moderate disability (mRs<3 )and ≥3)).  
 
Table 3 demonstrates that both SI and SBP are very good predictors of mortality outcomes 
with excellent area under the curves (AUC) for all of outcomes assessed. SI and SBP had the 
same AUC for both inpatient mortality and 3-day mortality with an AUC of 0.87 (95%CI: 
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0.85-0.89) and 0.91 (95% CI: 0.89-0.94), respectively. Both SI and SBP had a similarly high 
AUC for 7 day mortality. However, there was no significant difference between SI and SBP 
in any of the mortality outcomes with a p value of > 0.05 for each combined ROC curve 
analysis.  
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4.1 Discussion 
To our knowledge, this is the first study to examine the association between the shock index 
and acute mortality outcomes in stroke. We have found that both low and high values of the 
SI are associated with increased risk of 3-day and 7-day mortality, while only high values of 
the SI are associated with inpatient mortality. We have further shown that low and high levels 
of SBP are associated with inpatient and 7-day mortality. Both SI and SBP are very good 
predictors of morality outcomes, however there is little differentiation between the 
discriminating ability. Only low levels of SI are associated with 3-day mortality. Thus SI may 
be a useful indicator of very early mortality outcome in acute stroke. 
 
4.2 Context of findings  
A high SI has been reported to have a prognostic significance in conditions such as sepsis and 
severe volume depletion.
 6,13,14
  Previous research has shown that stroke patients with 
pneumonia and stroke associated infection are at an increased risk of mortality.
 15,16
  Thus, an 
explanation for a higher likelihood of mortality in the high SI group may be due to stroke 
associated infections. To our knowledge, this is the first study to show the predictive value of 
the higher shock index in stroke patients.  
 
Previous studies have used the SI to assess outcomes in patients with community acquired 
pneumonia, acute circulatory failure and predicting patients that require immediate intensive 
therapy.
 13,14,17,18
 Moreover, a recent study that used prospectively collected audit data 
showed that a SI of >1.0 was predictive of inpatient mortality in individuals age 90 years and 
over.
 19
 In this report, for the first time we have shown that low values of the SI were 
associated with very acute stroke outcomes; this indicates that mortality was higher among 
patients with signs of a low SI than those with a normal SI. A possible explanation for this is 
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that a low SI is only apparent in severe stroke injuries indicating severe insult to the brain. 
One possible explanation for this is the Cushing’s reflex, this is where there is a sharp rise in 
intracranial pressure (ICP) which attempts to maintain cerebral perfusion with resultant reflex 
bradycardia. Kalmer et al.
 20
 showed the Cushing reflex indicated by hypertension and 
bradycardia predicted poor intracranial perfusion and high ICP even during the neurological 
endoscopy, a minimally invasive procedure used in the management of brain tumors and 
tumor related hydrocephalus. Another study highlighted that mortality after a subarachnoid 
hemorrhage was predicted by high ICP, which demonstrated poor intracranial perfusion.
 
21
However, further work is required to assess whether there is a biologically plausible 
relationship between the Cushing’s reflex and acute stroke mortality. This will however 
require serial measurements of both heart rate and blood pressure.  
 
Previous research has shown that both high and low SBP measurements after stroke are 
associated with morality.
 2,22,23
 These studies showed that there was a U-shape relationship 
between systolic blood pressure and acute mortality outcome. The high levels of mortality in 
the fifth quintile could be explained by the high proportion of hemorrhagic strokes and 
previous history of hypertension seen in this sample. Previous research has suggested this 
association may be due an increased likelihood of a fatal cerebral edema in high SBP 
patients.
 24,25
 The association between low SBP (first quintile) and mortality may be due to 
inadequacy of cerebral perfusion due to low mean arterial pressure and subsequent reduce 
cerebral blood flow.
 2
 
 
4.3 Strengths of the study 
Our study is likely to be representative of the stroke population of the UK and western 
populations as it used a systematic sampling strategy over an adequately long time period 
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from eight different NHS trusts. As this is an observational study thus causation between the 
SI and poor stroke outcomes cannot be drawn. Nevertheless, the SI may be useful in 
providing prognostic information as well as in identifying those patients with stroke who are 
at highest risk of mortality outcomes. 
4.4 Limitations 
Our study has a few limitations. Although the study population is generalizable to the UK it 
may not reflect the case mix of other world regions due to the lack of ethnic diversity in this 
study population; the study population is mainly Caucasians (>95%). However, there is no 
reason to believe that other ethnic populations would have different physiological responses 
in stroke with regard to BP and HR. In the UK setting, NIHSS (National Institute of Health 
Stroke Scale) which is an acute stroke severity marker was not assessed routinely for all 
strokes. Therefore, we have NIHSS data available only in those who were assessed for 
thrombolysis treatment. However, we were able to control for OCSP classification which 
usually reflects the NIHSS. As with all quantitative studies missing values are an issue, 
missing values in the pre-stroke mRS reduced the size of the final model. Nevertheless, this 
may only have reduced the study power and only likely to attenuate the results. Whilst 
assessment of multiple outcomes may increase the risk of Type 1 errors, arguably prognostic 
information on very early mortality in stroke is very important clinically as this information 
can potentially guide the clinicians in making treatment decisions including appropriate level 
and place of care.  
 
5.1 Conclusion 
In summary, our study illustrated that SI and SBP are significant predictor of acute stoke 
morality. SI is a very simple index derived from two readily available vital signs at the time 
of stroke admission making it useful for the clinical setting. Given that the SI is an index, it is 
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likely to be more user friendly in clinical setting compared to continuous BP values. This 
paper uniquely highlights that patients at the extremes of the SI are at an increased likelihood 
of poor acute stroke mortality outcomes. Our results suggest that at low SI predicts very early 
mortality in stroke (3-day mortality) whilst high SI may be more useful beyond 3 days where 
complications and sepsis (e.g. post stroke pneumonia) are prevalent. While both high and low 
values of SBP were predictive of poor acute outcomes, SI has additional benefit of predicting 
3-day mortality. Further work should be replicated to support the findings of this study and 
should also examine whether incorporating SI in prognostic scoring systems would improve 
the clinical prediction rules in stroke.  
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Table 1: Sample characteristics of 2121 stroke patients in ASCNES (2009-2011) by quintiles of the Shock Index 
  
Quintiles of Shock Index 
 
  
Q1 Q2 Q3 Q4 Q5 
 Shock Index (SI) 0-0.396 0.397-0.467 0.468-0.542 0.543-0.643 0.645-1.5 
 SI (n) 424 423 426 423 425 P-value 
Age (Mean) 78 78 76 77 77 0.12 
Sex (% Male) 208 (49.1) 217 (51.3) 197 (46.4) 201 (47.5) 182 (42.8) 0.03 
Systolic Bp (Mean) 185 167 156 146 131 <0.0001 
Length of stay in days (mean) 15 15 17 16 18 0.14 
Heart rate (mean) 63 72 79 86 102 <0.0001 
pre-stroke modified Rankin  Scale (%) 
0 196 (54.6) 198 (54.8) 181 (49.5) 182 (51.4) 151 (43.3) 
<0.0001 
1 71 (19.8) 74 (20.5) 62 (16.9) 58 (16.4) 54 (15.5) 
2 30 (8.4) 31 (8.6) 47 (12.8) 46 (13.0) 33 (9.5) 
3 31 (8.6) 32 (8.9) 45 (12.3) 43 (12.1) 44 (12.6) 
4 20 (5.6) 17 (4.7) 23 (6.3) 15 (4.2) 50 (14.3) 
5 11 (3.1) 9 (2.5) 8 (2.2) 10 (2.8) 17 (4.9) 
Stroke type (%) Ischemic 352 (85.6) 348 (84.5) 359 (87.3) 368 (88.7) 369 (91.3) 0.003 
Oxford Stroke Project Classification (%) 
LACS
a
 93 (21.9) 102(24.1) 95 (22.3) 94 (22.2) 84 (19.8) 
0.08 
PACS
b 
151 (35.6) 148 (35.0) 147 (34.5) 160 (37.8) 140 (32.9) 
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POCS
c 
55 (13.0) 63 (14.9) 48 (11.3) 56 (13.2) 43 (10.1) 
TACS
d 
87 (20.0) 63 (14.9) 94 (22.1) 68 (16.1) 109 (25.6) 
Undetermined 40 (9.4) 47 (11.1) 42 (9.9) 45 (10.6) 49 (11.5) 
 
Treat for thrombolysis -  No (%) 402 (94.8) 403 (95.3) 403 (94.6) 403 (95.3) 408 (96.0) 0.47 
Pre-co-morbidities (Yes %) 
Myocardial Infarction 112 (26.4) 105 (24.8) 96 (22.5) 95 (22.5) 134 (31.5) 0.24 
Peripheral Vascular disease 13 (3.1) 21 (5.0) 13 (3.1) 15 (3.5) 21 (4.9) 0.43 
Diabetes Mellitus 75 (17.7) 72 (17.0) 66 (15.5) 70 (16.5) 85 (20.0) 0.50 
Hypertension 273 (64.4) 265 (62.6) 236 (55.4) 244 (57.7) 238 (56.0) 0.004 
Antihypertensive Rx 228 (53.8) 221 (52.2) 207 (48.6) 222 (52.5) 214 (50.4) 0.59 
Hypercholesterolemia 68 (16.0) 81 (19.1) 71 (16.7) 75 (17.7) 72 (16.9) 0.95 
COPD 12 (2.8) 23 (5.4) 27 (6.3) 30 (7.1) 37 (8.7) <0.0001 
Outcomes 
In patient mortality  n=419 73 (17.2) 70 (16.5) 74 (17.4) 74 (17.5) 128 (30.1) <0.0001 
3 Day mortality   n=158 35 (8.3) 22 (5.2) 25 (5.9) 29 (6.9) 47 (11.1) 0.07 
7 day mortality  n=245 49 (11.6) 43 (10.2) 34 (8.0) 45 (10.6) 74 (17.4) 0.01 
a
Lacunar Stroke;
 b
Partial Anterior Circulation Stroke; 
c
Posterior Circulation Stroke; 
d
Total Anterior Circulation Stroke 
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Table 2: Odds ratios of in-patient mortality, 3-day mortality and 7 day mortality in each of the quintiles of the Shock Index in ASCNES: logistic regression  
models 
 
Q1 Q2 Q3 Q4 Q5 
Outcomes and models OR 95% CI OR 95% CI Reference OR 95% CI OR 95% CI 
In-hospital mortality
e
 
         
A
a 
0.94 (0.65-1.35) 0.93 (0.65-1.35) 1 1.01 (0.70-1.46) 2.1 (1.50-2.94) 
B
b 
0.97 (0.64-1.46) 0.9 (0.59-1.36) 1 0.91 (0.60-1.38) 1.59 (1.08-2.35) 
C
c 
1.02 (0.63-1.64) 1.1 (0.68-1.78) 1 1.25 (0.77-2.02) 1.89** (1.20-2.97) 
D
d 
1.02 (0.63-1.66) 1.09 (0.67-1.78) 1 1.25 (0.77-2.03) 1.85** (1.17-2.92) 
          3-day mortality
e
 
         
A
a
 1.45 (0.85-2.49) 0.90 (0.50-1.63) 1 1.22 (0.70-2.14) 2.07** (1.24-3.46) 
B
b
 1.74* (0.93-3.23) 0.84 (0.41-1.73) 1 1.21 (0.62-2.34) 1.67 (0.91-3.08) 
C
c
 2.27* (1.09-4.74) 1.04 (0.45-2.41) 1 1.89 (0.86-4.15) 2.32* (0.86-4.15) 
D
d
 2.45* (1.16-5.17) 1.1 (0.47-2.58) 1 1.9 (0.86-4.19) 2.18* (1.03-4.63) 
          7-day mortality
e
 
         
A
a
 1.49* (0.94-2.38) 1.33 (0.82-2.14) 1 1.41 (0.88-2.26) 2.5*** (1.61-3.88) 
B
b
 1.56 (0.91-2.65) 1.33 (0.77-2.30) 1 1.38 (0.80-2.38) 1.86** (1.11-3.11) 
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C
c
 1.84 (0.99-3.41) 1.75 (0.93-3.30) 1 2.14* (1.14-4.03) 2.48** (1.36-4.54) 
D
d
 1.88* (1.01-3.49) 1.76 (0.93-3.35) 1 2.11* (1.12-3.99) 2.45** (1.34-4.49) 
          Inpatient mortality
f,d 
1.97* (1.19-3.26) 1.64 (0.99-2.73) 1 1.23 (0.73-2.06) 2.02*** (1.22-3.33) 
3 Day mortality
f,d 
1.84 (0.79-4.28) 0.82 (0.32-2.09) 1 1.5 (0.65-3.48) 2.58* (1.15-5.79) 
7 Day mortality
f,d 
2.09* (1.09-4.02) 1.00 (0.49-2.02) 1 1.63 (0.85-3.14) 2.23* (1.18-4.24) 
 
*<0.05 ** **≤0.01 ***≤0.001. eShock Index quintiles (Q1 (<0.396), Q2 (0.397-0.467), Q3 (0.468-0.542), Q4 (0.543-0.6430 and Q5 (0.645-1.50)). 
f
Systolic blood pressure quintiles (Q1 (<132mmHg), Q2 (132-148mmHg), Q3 (149-162mmHg), Q4 (163-182mmHg), Q5 (=>183mmHg) 
a
Model A age and sex adjusted (n=2116); 
b
Model B= Model A + mRS (n=1787); 
c
Model C= Model B + Oxford Stroke Project Classification +Stroke Type 
(n=1752); 
d
Model D =Model C + Previous Medical History +treated for thrombolysis (n=1752). 
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Table 3. The comparison of the receiver operating characteristic (ROC) curve analysis, examining the difference in the discriminating ability between quintiles  
of the shock index and systolic blood pressure. 
  
Area under ROC 
curve 
95% CI P-value χ2 Value 
Inpatient 
mortality 
Shock Index model 0.87 (0.84-0.89) 
0.85 0.04 
Systolic blood pressure model 0.87 (0.85-0.89) 
      
3-day 
mortality 
Shock Index model 0.91 (0.89-0.94) 
0.63 0.23 
Systolic blood pressure model 0.91 (0.89-0.94) 
      
7-day 
mortality 
Shock Index model 0.86 (0.83-0.89) 
0.26 0.61 
Systolic blood pressure model 0.87 (0.84-0.90) 
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Supplementary Table 1: Sample characteristics of 2,121 stroke patients in ASCNES (2009-2011) by quintiles of the systolic blood pressure 
  
Quintiles of systolic blood pressure 
 
  
Q1 Q2 Q3 Q4 Q5 
 Quintiles (mmHg) <131 132-148 149-162 163-182 ≥163 
 
 
425 (20.0) 449 (21.2) 416 (19.6) 419 (19.8) 412 (19.4) P-value 
Age (Mean) 76 76 78 78 78 0.122 
Sex (% Male) 209 (49.2) 207 (46.2) 216 (51.9) 191 (45.6) 182 (44.2) 0.175 
LOS (mean) 16 17 16 15 14 0.074 
Heart rate (mean) 81 80 81 80 81 0.746 
pre-stroke modified Rankin  Score (%) 
0 149 (42.8) 216 (56.5) 181 (50.8) 176 (49.3) 186 (53.8) 
0.007 
1 58 (16.7) 58 (15.2) 76 (21.3) 64 (17.9) 63 (18.2) 
2 38 (10.9) 38 (9.9) 33 (9.3) 48 (13.4) 30 (8.7) 
3 47 (13.5) 39 (10.2) 39 (11.0) 38 (10.6) 32 (9.2) 
4 39 (11.2) 21 (5.5) 22 (6.2) 20 (5.6) 23 (6.6) 
5 17 (4.9) 10 (2.6) 5 (1.4) 11 (3.1) 12 (3.5) 
Stroke type (%) Ischaemic 368 (90.9) 401 (91.8) 356 (88.6) 351 (85.6) 320 (80.2) ≤0.001 
Oxford Stroke Project Classification (%) 
LACS
a
 98 (23.1) 95 (21.2) 93 (22.4) 95 (22.7) 87 (21.1) 
0.921 PACS
b
 124 (29.2) 174 (38.8) 169 (40.6) 149 (35.6) 130 (31.6) 
POCS
c
 56 (13.2) 50 (11.1) 54 (13.0) 52 (12.4) 53 (12.9) 
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TACS
d
 97 (22.8) 85 (18.9) 62 (14.9) 78 (18.6) 97 (23.5) 
Undetermined 50 (11.8) 45 (10.0) 38 (9.1) 45 (10.7) 45 (10.9) 
 
Treat for thrombolysis - Yes (%) 27 (6.4) 24 (5.3) 21 (5.0) 19 (4.5) 11 (2.7) 0.014 
Pre-co-morbidities (Yes %) 
Myocardial Infarction 138 (32.5) 110 (24.5) 107 (25.7) 107 (25.5) 80 (19.4) ≤0.001 
Peripheral Vascular disease 23 (5.4) 14 (3.1) 18 (4.3) 13 (3.1) 15 (3.6) 0.240 
Diabetes Mellitus 89 (20.9) 57 (12.7) 69 (16.6) 73 (17.4) 80 (19.4) 0.754 
Hypertension 242 (56.9) 248 (55.2) 228 (54.8) 277 (66.1) 261 (63.3) 0.002 
Antihypertensive Rx 221 (52.0) 226 (50.3) 205 (49.3) 235 (26.1) 205 (49.8) 0.857 
Hypercholesterolemia 70 (16.5) 91 (20.3) 70 (16.8) 69 (16.5) 67 (16.3) 0.471 
COPD 28 (6.6) 37 (8.2) 22 (5.3) 29 (6.9) 13 (3.2) 0.026 
Outcomes 
In patient mortality  n=419 108 (25.4) 82 (18.3) 52 (12.5) 73 (17.4) 104 (25.2) 0.818 
3 Day mortality   n=158 44  (10.4) 21 (4.7) 17 (4.1) 28 (6.7) 48 (11.7) 0.261 
7 day mortality  n=245 69 (16.2) 35 (7.8) 25 (6.0) 47 (11.2) 69 (16.7) 0.374 
a
Lacunar Stroke;
 b
Partial Anterior Circulation Stroke; 
c
Posterior Circulation Stroke; 
d
Total Anterior Circulation Stroke 
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Supplementary Table 2: Odds Ratios of  in-patient mortality, 3-day mortality and 7-day mortality using normal range values of Shock Index as cut off points in stratified 
analyses by age categories, sex, stroke classification, prestroke disability and in ischemic stroke subtype. 
   
<0.5 95% CI 0.5-0.69 >0.7 95% CI 
Age 
In patient mortality 
<65 0.26 0.04-1.85 1 5.52 (0.83-36.61) 
≥65 0.99 (0.70-1.39) 1 1.96*** (1.24-3.11) 
3 Day mortality 
<65 0.75 (0.01-40.35) 1 0.27 (0.00-27.89) 
≥65 1.22 (0.70-2.12) 1 2.46** (1.2-5.02) 
7 Day mortality 
<65 .750 (0.08-7.42) 1 5.69 (0.26-126.56) 
≥65 1.05 (0.68-1.61) 1 1.74 (0.98-3.08) 
        
Sex 
In patient mortality 
Female 1.1 (0.71-1.72 1 2.35** (1.30-4.28) 
Male 0.76 (0.45-1.29) 1 2.14* (1.09-4.19) 
3 Day mortality 
Female 1.16 (0.58-2.33) 1 2.18 (0.84-5.63) 
Male 1.45 (0.60-3.52) 1 2.94 (1.00-8.68) 
7 Day mortality 
Female 1.39 (0.80-2.43) 1 2.56* (1.23-5.34) 
Male 0.78 (0.40-1.54) 1 1.48 (0.61-3.58) 
        
Oxford Stroke Project Classification 
In patient mortality 
Other type 0.87 (0.57-1.34) 1 2.21** (1.27-3.82) 
TACS 1.21 (0.70-2.07) 1 2.34* (1.13-4.83) 
3 Day mortality 
Other type 0.92 (0.41-2.06) 1 2.8 (0.98-8.02) 
TACS 1.66 (0.79-3.47) 1 2.46 (1.00-6.08) 
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*<0.05 **≤0.01 ***≤0.001. Models adjusted for age, sex, mRS, Oxford Stroke Project Classification, Stroke Type, previous co-morbidities, treated for thrombolysis. aOnly 
included Ischemic strokes in analysis. 
 
 
 
 
7 Day mortality 
Other type 0.93 (0.51-1.69) 1 2.74* (1.29-5.81) 
TACS 1.29 (0.71-2.32) 1 1.45 (0.68-3.10) 
        
Pre-stroke mRS 
In patient mortality 
<3 1.06 (0.70-1.61) 1 3.27*** (1.85-5.78) 
≥3 0.75 (0.44-1.26) 1 1.4 (0.77-2.53) 
3 Day mortality 
<3 1.81 (0.91-3.61) 1 2.73** (1.01-7.38) 
≥3 0.6 (0.28-1.30) 1 1.39 (0.63-3.04) 
7 Day mortality 
<3 1.18 (0.71-1.95) 1 1.92 (0.92-3.99) 
≥3 0.89 (0.47-1.71) 1 2.10* (1.05-4.18) 
        
Stroke Type – Ischemic
a
 
In patient mortality 
 
0.84 (0.57-1.23) 1 1.94** (1.21-3.11) 
3 Day mortality 0.87 (0.41-1.84) 1 2.06 (0.92-4.58) 
7 Day mortality 0.77 (0.46-1.30) 1 1.58 (0.86-2.88) 
